MAGELLAN HEALTH INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash from operating activities:
Non-cash impairment of intangible assets
Depreciation and amortization
Special charges
Gain on sale of MCC
Non-cash interest expense
Non-cash income tax provision
Non-cash stock compensation expense
Non-cash income tax (benefit) provision
Non-cash accretion (amortization) on investments

Changes in assets and liabilities, net of effects from acquisitions of businesses:
Accounts receivable, net
Pharmaceutical inventory
Other assets
Accounts payable and accrued liabilities
Medical claims payable and other medical liabilities
Contingent consideration
Tax contingencies
Deferred credits and other long-term liabilities
Other
Net cash provided by operating activities
Net cash provided by (used in) operating activities from discontinued operations
Net cash provided by operating activities from continuing operations
Cash flows from investing activities:
Capital expenditures
Acquisitions and investments in businesses, net of cash acquired
Sale of MCC
Purchases of investments
Proceeds from maturities and sales of investments
Net cash (used in) provided by investing activities
Net cash (used in) provided by investing activities from discontinued operations
Net cash (used in) provided by investing activities from continuing operations
Cash flows from financing activities:
Proceeds from issuance of debt
Proceeds from borrowings on revolving line of credit
Payments to acquire treasury stock
Proceeds from exercise of stock options
Payments on debt, finance lease and deferred financing obligations
Payments on contingent consideration
Other
Net cash (used in) provided by financing activities
Net cash (used in) provided by financing activities from discontinued operations
Net cash (used in) provided by financing activities from continuing operations

Net increase (decrease) in cash and cash equivalents
Net (decrease) increase in cash and cash equivalents from continuing operations
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Assets acquired under finance leases and deferred financing

Comments